A TNF-Regulated Recombinatorial Macrophage Immune Receptor Implicated in Granuloma Formation in Tuberculosis-Reference-Cited by-同舟云学术

A TNF-Regulated Recombinatorial Macrophage Immune Receptor Implicated in Granuloma Formation in Tuberculosis

Published:2011-11-17 Issue:11 Volume:7 Page:e1002375
ISSN:1553-7374
Container-title:PLoS Pathogens
language:en
Short-container-title:PLoS Pathog

Author:

Beham Alexander W.,Puellmann Kerstin,Laird Rebecca,Fuchs Tina,Streich Roswita,Breysach Caroline,Raddatz Dirk,Oniga Septimia,Peccerella Teresa,Findeisen Peter,Kzhyshkowska Julia,Gratchev Alexei,Schweyer Stefan,Saunders Bernadette,Wessels Johannes T.,Möbius Wiebke,Keane Joseph,Becker Heinz,Ganser Arnold,Neumaier Michael,Kaminski Wolfgang E.

Publisher

Public Library of Science (PLoS)

Subject

Virology,Genetics,Molecular Biology,Immunology,Microbiology,Parasitology

Reference32 articles.

1. Innate immune recognition.;CA Janeway Jr;Annu Rev Immunol,2002

2. Global burden and epidemiology of tuberculosis.;P Glaziou;Clin Chest Med,2009

3. Illuminating the black box of TNF action in tuberculous granulomas.;EA Miller;Immunity,2008

4. Tuberculosis: back on the immunologists' agenda.;SH Kaufmann;Immunity,2006

5. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent.;J Keane;N Engl J Med,2001

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enrichment of novel CD3+F4/80+ cells in brown adipose tissue following adrenergic stimulation;Frontiers in Immunology;2024-08-27

2. Multiomics integration-based immunological characterizations of adamantinomatous craniopharyngioma in relation to keratinization;Cell Death & Disease;2024-06-21

3. Automated quantitative assay of fibrosis characteristics in tuberculosis granulomas;Frontiers in Microbiology;2024-01-03

4. MAIT cells confer resistance to Lenvatinib plus anti-PD1 antibodies in hepatocellular carcinoma through TNF-TNFRSF1B pathway;Clinical Immunology;2023-11

5. Opportunistic Infections and Immune-Related Adverse Events Associated with Administering Immune Checkpoint Inhibitors: A Narrative Review;Pharmaceuticals;2023-08-09